Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -64.42% is 92% above its 5-year average of -858.61%, near the high end of its 5-year range (-5060.81%–170.50%).
19.04% above its 12-month average of -79.57%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -16.12%.
RETURN ON ASSETS (ROA)
-64.42%
RETURN ON ASSETS (ROA) AVG TTM
-79.57%
RETURN ON ASSETS (ROA) AVG 3Y
-65.34%
RETURN ON ASSETS (ROA) AVG 5Y
-858.61%
RETURN ON ASSETS (ROA) AVG 10Y
-2309.04%
RETURN ON ASSETS (ROA) AVG 15Y
-1864.25%
RETURN ON ASSETS (ROA) AVG 20Y
-1711.48%
CURRENT VS TTM AVG
+19.04%
CURRENT VS 3Y AVG
+1.40%
CURRENT VS 5Y AVG
+92.50%
CURRENT VS 10Y AVG
+97.21%
CURRENT VS 15Y AVG
+96.54%
CURRENT VS 20Y AVG
+96.24%
SECTOR MEDIAN · HEALTHCARE
-26.34%
median of 496 covered companies
CURRENT VS SECTOR MEDIAN
-144.52%
vs the sector median at left
Creative Medical Technology Holdings, Inc.
Market Cap
$2.37M
Return on Assets (ROA)
-64.42%
TTM Avg
-79.57%
3Y Avg
-65.34%
5Y Avg
-858.61%
Market Cap
$2.38M
Return on Assets (ROA)
-56.04%
TTM Avg
-32.94%
3Y Avg
-18.68%
5Y Avg
-12.05%
Market Cap
$2.36M
Return on Assets (ROA)
-439.95%
TTM Avg
-322.44%
3Y Avg
-242.34%
5Y Avg
-192.54%
Market Cap
$2.47M
Return on Assets (ROA)
-228.77%
TTM Avg
-130.86%
3Y Avg
-126.84%
5Y Avg
-140.90%
Market Cap
$2.59M
Return on Assets (ROA)
-199.30%
TTM Avg
-137.41%
3Y Avg
-109.57%
5Y Avg
-977.62%
Market Cap
$2.64M
Return on Assets (ROA)
-154.47%
TTM Avg
-121.84%
3Y Avg
-88.87%
5Y Avg
-75.91%
Market Cap
$2.05M
Return on Assets (ROA)
-107.18%
TTM Avg
-105.74%
3Y Avg
-98.21%
5Y Avg
-95.08%
Market Cap
$1.92M
Return on Assets (ROA)
-404.67%
TTM Avg
-168.15%
3Y Avg
-182.58%
5Y Avg
-275.93%
Market Cap
$3.09M
Return on Assets (ROA)
-238.27%
TTM Avg
-211.11%
3Y Avg
-146.32%
5Y Avg
-173.65%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Creative Medical Technology Holdings, Inc. (CELZ) | $2.37M | -64.42% | -79.57% | -65.34% | -858.61% |
| iTonic Holdings Ltd. (ITOC)vs › | $2.38M | -56.04% | -32.94% | -18.68% | -12.05% |
| GeoVax Labs, Inc. (GOVX)vs › | $2.36M | -439.95% | -322.44% | -242.34% | -192.54% |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.47M | -228.77% | -130.86% | -126.84% | -140.90% |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.59M | -199.30% | -137.41% | -109.57% | -977.62% |
| iSpecimen Inc. (ISPC)vs › | $2.64M | -154.47% | -121.84% | -88.87% | -75.91% |
| Jaguar Health, Inc. (JAGX)vs › | $2.05M | -107.18% | -105.74% | -98.21% | -95.08% |
| Autonomix Medical, Inc. (AMIX)vs › | $1.92M | -404.67% | -168.15% | -182.58% | -275.93% |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.09M | -238.27% | -211.11% | -146.32% | -173.65% |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.13M | -80.08% | -84.48% | -250.02% | -187.49% |
ROA
-64.4%
ROE
-69.8%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -76.77% |
| 2024-12-31 | -82.37% |
| 2023-12-31 | -49.34% |
| 2022-12-31 | -52.87% |
| 2021-12-31 | 170.50% |
| 2020-12-31 | -5060.81% |
| 2019-12-31 | -1598.27% |
| 2018-12-31 | -2861.85% |
| 2017-12-31 | -1308.96% |
| 2016-12-31 | -237.53% |
| 2015-12-31 | -14241.20% |
| 2014-12-31 | -2936.27% |
| 2013-12-31 | -7294.65% |
| 2012-12-31 | -1631.70% |
| 2011-12-31 | -774.72% |
| 2010-12-31 | -4168.12% |
| 2009-12-31 | -1027.97% |
| 2008-12-31 | -3504.39% |
| 2007-12-31 | -26.79% |
| 2006-12-31 | 4.68% |
